Akèy › Kansè nan tete › Kansas › Overland Park
Etid klinik pou Kansè nan tete nan Overland Park, KS
10 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Overland Park (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Ap rekriteFaz 1/2
- University of Kansas Hospital-Cancer Center, Fairway · 3 mi lwen
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Ap rekriteFaz 3
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- KCCC Overland Park, Overland Park
- Overland Park Regional Medical Center, Overland Park
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Ap rekriteFaz 3
- University of Kansas Cancer Center-Overland Park, Overland Park
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
Ap rekriteFaz 2
- University of Kansas Medical Center, Fairway · 3 mi lwen
Integrated Cancer Repository for Cancer Research
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Saint Luke's Cancer Instititute - South, Overland Park
Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer
Ap rekriteFaz 2
- KUCC - Indian Creek, Overland Park
- KUCC - Overland Park, Overland Park
- The University of Kansas Cancer Center (KUCC), Fairway · 3 mi lwen
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Ap rekriteFaz 3
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Ap rekriteEtid obsèvasyon
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Ap rekriteFaz 3
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
Etid Kansè nan tete nan lòt vil
- New York City, NY136 etid
- Houston, TX126 etid
- Boston, MA112 etid
- Nashville, TN81 etid
- Los Angeles, CA73 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Queens, NY64 etid
- Durham, NC64 etid
- Chicago, IL59 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
Lòt etid nan Overland Park
- Kansè Poumon ki pa ti selil16 etid
- Leksemi mieloïd egi11 etid
- Kansè poumon11 etid
- Fibrilasyon atriyal8 etid
- Kansè kolorektal8 etid
- Obèsite7 etid
- Kansè pankreyas7 etid
- Kansè pwostat7 etid
- Melanom6 etid
- Sipwa6 etid
- Kansè ovè6 etid
- Kansè (tout kalite)5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.